In 2020, the MedTech industry faced revenue pressures as COVID related headwinds forced many patients to avoid the hospital for elective procedures. As COVID risks fade, the industry has returned to growth and the demographic and innovation tailwinds that have helped to drive steady growth remain. Travis joins us to discuss how some of the biggest MedTech markets, from diabetes to heart surgery, will benefit from continued innovation, helping the group and potentially millions of patients. And thus far, MedTech has actually benefitted from the increase in the number of surgeries done outside of the hospital. Travis also highlights that hospitals are now better equipped to handle future COVID spikes and MedTech should remain resilient even through a negative economic backdrop.

"Bank of America" and “BofA Securities” are the marketing names for the global banking businesses and global markets businesses (which includes BofA Global Research) of Bank of America Corporation. Lending, derivatives, and other commercial banking activities are performed globally by banking affiliates of Bank of America Corporation, including Bank of America, N.A., Member FDIC. Securities, trading, research, strategic advisory, and other investment banking and markets activities are performed globally by affiliates of Bank of America Corporation, including, in the United States, BofA Securities, Inc. a registered broker-dealer and Member of FINRA and SIPC, and, in other jurisdictions, by locally registered entities.

©2022 Bank of America Corporation. All rights reserved.